The Five Dumbest Things on Wall Street This Week

The Five Dumbest Things on Wall Street This Week

 

5. Offensive Defense

Merck's (MRK) legal defense may have gotten a little too vigorous for its own good.

On Friday, a jury in Rio Grande City, Texas, found the company liable for the death of a 71-year-old man who had a fatal heart attack within a month of taking Vioxx, Merck's now infamous painkiller. Merck pulled Vioxx on Sept. 30, 2004, after research established a heart attack link, spurring the filing of more than 10,000 lawsuits. The $32 million award marked Merck's third loss in six Vioxx trials.

In closing statements, The Associated Press reports, Merck lawyer Richard Josephson reviewed the victim's history of heart disease, beginning with a quadruple bypass in 1989. He also noted the victim's smoking habit.

"He had every single risk factor that you can have," Josephson said of the late Leonel Garza. "The idea that Mr. Garza was in good health and only had a 1% chance of having a heart attack is science fiction."

Then, according to the AP, Josephson hammered home his point. "You'll see that Mr. Garza's time was up," he blathered to jurors.

The way things are going in the Vioxx case, we'll soon be saying the same of Merck.

Dumb-o-Meter score: 80. Of course, Merck has never engaged in any science fiction itself.

>To order reprints of this article, click here: Reprints

In our award-winning effort to enrich the reader experience, the Five Dumbest Things Lab now scores each item using our proprietary Dumb-o-Meter. This cutting-edge technology employs a finely calibrated, 100-point scale measuring sheer Dumbness, as calculated via a closely guarded secret formula.

Got your own idea for the dumbest thing of the week? Let us know.

Want to get your Five Dumbest in the mail? It's easy. Just become a TSC member -- it's free -- and you'll receive the Five Dumbest in our Before the Bell email newsletter every Friday. The rest of the week, before each trading day, Before the Bell gives you a comprehensive look at the stocks expected to move the market, plus access to a sampling of our premium content from RealMoney. Click here to sign up for Before the Bell!

TheStreet Premium Services

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
Dow Jones S&P 500 NASDAQ 10-Year Note
12,419.86 1,313.32 2,837.36 16.25
Oil *
103.00
DOWN
160.83
DOWN
19.10
DOWN
33.63
DOWN
1.06
10 Yr
1.62%
SPDR Gold
151.91
-1.28%
-1.43%
-1.17%
-6.12%
Data delayed 20 minutes

Top Stories and Tools

Articles From

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet